Repare Therapeutics
RPTX
RPTX
67 hedge funds and large institutions have $689M invested in Repare Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 66 → 67 (+1)
3% less capital invested
Capital invested by funds: $708M → $689M (-$18.2M)
7% less call options, than puts
Call options by funds: $207K | Put options by funds: $223K
Holders
67
Holding in Top 10
5
Calls
$207K
Puts
$223K
Top Buyers
| 1 | +$35.4M | |
| 2 | +$24M | |
| 3 | +$5.73M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.29M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.01M |
Top Sellers
| 1 | -$6.53M | |
| 2 | -$5.82M | |
| 3 | -$3.48M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.63M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.44M |